SPS
RCKT icon

Susquehanna Portfolio Strategies’s Rocket Pharmaceuticals RCKT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
332,106
+71,297
+27% +$237K 0.02% 545
2026
Q1 		$934K Sell
260,809
-173,600
-40% -$690K 0.01% 648
2025
Q4 		$1.52M Hold
434,409
– – 0.02% 560
2025
Q3 		$1.42M Hold
434,409
– – 0.02% 589
2025
Q2 		$1.06M Buy
434,409
+402,313
+1,253% +$2.04M 0.02% 492
2025
Q1 		$214K Buy
+32,096
New +$317K 0.09% 119

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Susquehanna Portfolio Strategies's RCKT Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Rocket Pharmaceuticals (RCKT) stake by 27% in Q2 2026, buying an estimated $237K and bringing the position to 332,106 shares worth $1.14M. The position accounts for 0.02% of the portfolio, ranked #545.

Susquehanna Portfolio Strategies first reported a position in RCKT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.52M in Q4 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Susquehanna Portfolio Strategies held 332,106 shares of Rocket Pharmaceuticals worth $1.14M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 71,297 Rocket Pharmaceuticals shares in Q2 2026, an estimated $237K.
  • Rocket Pharmaceuticals made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #545 holding.
  • Susquehanna Portfolio Strategies first reported a position in Rocket Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Susquehanna Portfolio Strategies's Rocket Pharmaceuticals position peaked at $1.52M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.